Newsroom
Latest press releases will be shared here anytime. Stay tuned!
20250527 GlycoNex Publishes GNX201 Study Using PrecisemAb Antibody Lock in Int J Biol Macromol
2025-06-04 15:56:25PrecisemAb Biotech Co., Ltd. congratulates GlycoNex Inc. on their latest publication!
We are proud to have collaborated with GlycoNex in the development of GNX201, a tumor-region-selective pro-antibody empowered by our proprietary AntibodyLock technology.
GlycoNex recently announced the publication of this research in the International Journal of Biological Macromolecules:
(Impact factor:7.7, https://www.sciencedirect.com/science/article/abs/pii/S0141813025037286 )
This study highlights how GNX201 leverages the Antibody Lock mechanism to selectively activate in tumor microenvironments, reducing systemic toxicity while maintaining efficacy — a promising step forward for safer, targeted antibody therapeutics.
We remain committed to advancing this innovative platform globally to help build a safer and more effective new generation of antibody therapeutics.
For the official press release, please see:
English News |
TOP